Generated by GPT-5-mini| Open Philanthropy Project | |
|---|---|
| Name | Open Philanthropy Project |
| Formation | 2014 |
| Type | Philanthropic foundation |
| Headquarters | United States |
| Founders | Dustin Moskovitz; Cari Tuna |
| Focus | Global health; biosecurity; criminal justice reform; policy research; animal welfare; scientific research |
Open Philanthropy Project is a philanthropic grantmaker founded by Dustin Moskovitz and Cari Tuna that emerged from the philanthropic activities associated with the founders of Facebook and later philanthropy networks. It combined high-impact giving principles with systematic research methods influenced by effective altruism communities and large donor networks, and it became known for large unrestricted grants to public institutions, scientific organizations, and advocacy groups. The organization has been a major actor in debates on global catastrophic risks, biomedical research funding, and criminal justice reform, and it has collaborated with universities, think tanks, biotechnology centers, and nonprofit organizations.
The origins trace to the early philanthropic work of Dustin Moskovitz and Cari Tuna and their association with networks tied to Peter Thiel, Elon Musk, and other Silicon Valley donors, paralleling initiatives such as the Thiel Fellowship, the Chan Zuckerberg Initiative, and the Bill & Melinda Gates Foundation. Early activities drew on methodologies championed by philosophers and organizations like William MacAskill, Toby Ord, and the Centre for Effective Altruism, while associating with institutions such as Harvard University, Stanford University, and the Massachusetts Institute of Technology through grant partnerships. As the project expanded, it engaged with biosecurity researchers at institutions including the Johns Hopkins Center for Health Security, the National Institutes of Health, and the World Health Organization, and it funded criminal justice research aligned with work by the Vera Institute of Justice and the Brennan Center for Justice. The organization’s evolving portfolio reflected shifts seen in major philanthropic actors like the Rockefeller Foundation, the Walton Family Foundation, and the Ford Foundation, and it periodically updated public strategy documents akin to policy papers by the RAND Corporation and the Brookings Institution.
The stated mission emphasized reducing suffering and protecting long-term flourishing through targeted grants informed by empirical research and cost-effectiveness analysis, drawing intellectual influence from moral philosophers and organizations such as Peter Singer, the Future of Humanity Institute, and the Global Priorities Institute. Its strategic approach combined programmatic focus areas—global health and development, biosecurity and pandemic preparedness, animal welfare, criminal justice reform, and scientific research—with fund allocation practices similar to those used by the Gates Foundation, Open Society Foundations, and the Wellcome Trust. Strategy development entailed commissioning work from research centers like the National Bureau of Economic Research, the London School of Economics, and the University of Oxford, and leveraging partnerships with policy platforms including the Center for American Progress and the Heritage Foundation to inform advocacy pathways.
Governance included a board and leadership team drawn from philanthropic and policy backgrounds, paralleling governance models used by the Rockefeller Brothers Fund, the Hewlett Foundation, and the MacArthur Foundation. Key decision-makers engaged with external advisors from academic institutions such as Yale University, Princeton University, and Columbia University, and consulted with experts affiliated with the Centers for Disease Control and Prevention and the Food and Agriculture Organization. Funding sources primarily originated from the personal philanthropy of the founders and aligned donor-advised funds, resembling patterns seen at Fidelity Charitable and the Silicon Valley Community Foundation, and grants were disbursed to nonprofit organizations, universities, and research consortia like the Wellcome Trust and the Gates Foundation. Financial oversight and compliance were managed with practices comparable to those of the Internal Revenue Service reporting for 501(c)(3) organizations and audit standards used by major foundations like the Carnegie Corporation.
The portfolio included high-profile grants to institutions across public health, biosecurity, and social reform, such as large awards supporting epidemic modeling at Imperial College London, vaccine research at the Salk Institute, and laboratory infrastructure at institutions like MIT and Stanford. It funded criminal justice programs with partners including the ACLU, the Sentencing Project, and the Prison Policy Initiative, and invested in animal welfare initiatives alongside organizations such as The Humane League and the Good Food Institute. In biosecurity, it supported research at the Broad Institute, the White House Office of Science and Technology Policy initiatives, and collaborative projects with the World Health Organization and the Coalition for Epidemic Preparedness Innovations. Grants also supported basic science through fellowships and lab funding at institutions like Caltech, the Howard Hughes Medical Institute, and the National Science Foundation-funded centers.
Assessment methods emphasized evidence synthesis, randomized evaluations, and cost-effectiveness metrics similar to approaches used by the Abdul Latif Jameel Poverty Action Lab, 3ie, and the Cochrane Collaboration. The organization sponsored meta-research with partners including the Center for Global Development, the Institute for Health Metrics and Evaluation, and the Econometric Society to estimate global burden reduction and intervention value, and it employed external reviews drawing on expertise from the National Academy of Sciences and the Royal Society. Transparency practices included public reports and cause-area analyses akin to white papers from the RAND Corporation and working papers circulated through the National Bureau of Economic Research, while monitoring and evaluation frameworks mirrored OECD DAC guidance and philanthropic standards used by the Council on Foundations.
Critics raised questions about donor influence, priority-setting by high-net-worth individuals, and the ethics of risk-focused funding, echoing debates involving the Gates Foundation, the Chan Zuckerberg Initiative, and large private foundations. Commentators in venues referencing the New Yorker, the Atlantic, and academic critiques from journals associated with Oxford and Yale raised concerns about transparency, accountability, and the epistemic limits of cost-effectiveness models applied to existential risk and biosecurity. Controversies included debates over specific grants to research groups at universities such as Harvard and the Salk Institute, discussions with policymakers in the European Commission, and scrutiny from advocacy organizations like Public Citizen and ProPublica. Responses to criticism involved engagement with independent evaluators, updated publication of grant rationales, and alignment efforts with international standards promoted by the World Health Organization and the United Nations.
Category:Foundations in the United States